SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 92 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,192 | -11.0% | 7,026,141 | +37.1% | 0.00% | 0.0% |
| Q2 2023 | $30,536 | +107.0% | 5,123,428 | +13.6% | 0.00% | +100.0% |
| Q1 2023 | $14,751 | -12.4% | 4,510,786 | +5.8% | 0.00% | -33.3% |
| Q4 2022 | $16,844 | -99.9% | 4,264,492 | +17.1% | 0.00% | -25.0% |
| Q3 2022 | $21,844,000 | +17.5% | 3,640,503 | +25.9% | 0.00% | +100.0% |
| Q2 2022 | $18,593,000 | +9.8% | 2,891,581 | +41.0% | 0.00% | 0.0% |
| Q1 2022 | $16,934,000 | -9.2% | 2,050,133 | +70.2% | 0.00% | 0.0% |
| Q4 2021 | $18,649,000 | -30.2% | 1,204,696 | +1.5% | 0.00% | -33.3% |
| Q3 2021 | $26,734,000 | +14.3% | 1,187,109 | -0.3% | 0.00% | +50.0% |
| Q2 2021 | $23,399,000 | -42.1% | 1,190,199 | -1.4% | 0.00% | -50.0% |
| Q1 2021 | $40,389,000 | – | 1,206,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |